The U.S. Court of Appeals for the Federal Circuit ruled Friday that isolated DNA molecules are patentable, but struck down Myriad Genetics' method claim for comparing DNA sequences.
Subscribe to BioWorld™ news services
The U.S. Court of Appeals for the Federal Circuit ruled Friday that isolated DNA molecules are patentable, but struck down Myriad Genetics' method claim for comparing DNA sequences.